Research Progress of Biomarkers in Metabolic Syndrome
Abstract：Metabolic Syndrome (MetS) is considered a complex syndrome of metabolic disorders, characterized mainly by central obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low serum high-density lipoprotein. The exact etiology of MetS has not been fully elucidated. However, multiple studies have reported a close relationship between MetS and insulin resistance, oxidative stress, inflammation, obesity, endothelial dysfunction, and cardiovascular diseases [1,2]. A current epidemiological survey in China revealed that the prevalence of MetS among people aged 20 and above is 31.1%, especially with an increasing trend in females, those aged 45 and above, and urban residents [3].
Machine-generated Keywords：
Publication Date：2025-05-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 632-635 )